Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 398285, 9 pages
http://dx.doi.org/10.1155/2014/398285
Research Article

Flutamide-Induced Cytotoxicity and Oxidative Stress in an In Vitro Rat Hepatocyte System

1Department of Pharmacology & Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada M5S 1A8
2Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada M5S 3M2

Received 27 May 2014; Revised 1 September 2014; Accepted 20 September 2014; Published 13 October 2014

Academic Editor: Jing Yi

Copyright © 2014 Abdullah Al Maruf and Peter O’Brien. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Steinsapir, G. Mora, and T. G. Muldoon, “Effects of steroidal and non-steroidal antiandrogens on the androgen binding properties of the rat ventral prostate androgen receptor,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1094, no. 1, pp. 103–112, 1991. View at Publisher · View at Google Scholar · View at Scopus
  2. J.-L. Gomez, A. Dupont, L. Cusan et al., “Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients,” The American Journal of Medicine, vol. 92, no. 5, pp. 465–470, 1992. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Berson, C. Wolf, C. Chachaty et al., “Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies,” Journal of Pharmacology and Experimental Therapeutics, vol. 265, no. 1, pp. 366–372, 1993. View at Google Scholar · View at Scopus
  4. N. Asakawa, “Studies on the metabolic fate of flutamide (4): biliary excretion, enterohepatic circulation, absorption from gastro-intestinal tract, metabolism and drug-metabolizing enzymes induction in rats,” Xenobiotic Metabolism and Disposition, vol. 10, pp. 470–483, 1995. View at Google Scholar
  5. H.-X. Wang, X.-C. Ma, Q.-L. Deng, and D. Li, “Cytotoxicity of flutamide and 2-hydroxyflutamide and their effects on CYP1A2 mRNA in primary rat hepatocytes,” Acta Pharmacologica Sinica, vol. 23, no. 6, pp. 562–566, 2002. View at Google Scholar · View at Scopus
  6. D. Fau, D. Eugene, A. Berson et al., “Toxicity of the antiandrogen flutamide in isolated rat hepatocytes,” Journal of Pharmacology and Experimental Therapeutics, vol. 269, no. 3, pp. 954–962, 1994. View at Google Scholar · View at Scopus
  7. W. Hart and B. H. Stricker, “Flutamide and hepatitis,” Annals of Internal Medicine, vol. 110, no. 11, pp. 943–944, 1989. View at Google Scholar · View at Scopus
  8. N. D. McDonnell and R. B. Livingston, “Severe reversible neutropenia following treatment of prostate cancer with flutamide,” Journal of Urology, vol. 151, no. 5, pp. 1353–1354, 1994. View at Google Scholar · View at Scopus
  9. R. Srinivasan, J. P. Buchweitz, and P. E. Ganey, “Alteration by flutamide of neutrophil response to stimulation: implications for tissue injury,” Biochemical Pharmacology, vol. 53, no. 8, pp. 1179–1185, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. S. L. MacAllister, A. A. Maruf, L. Wan, E. Chung, and P. O'Brien, “Modeling xenobiotic susceptibility to hepatotoxicity using an in vitro oxidative stress inflammation model,” Canadian Journal of Physiology and Pharmacology, vol. 91, no. 3, pp. 236–240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. P. E. Ganey and R. A. Roth, “Concurrent inflammation as a determinant of susceptibility to toxicity from xenobiotic agents,” Toxicology, vol. 169, no. 3, pp. 195–208, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Pérez-Matute, M. A. Zulet, and J. A. Martínez, “Reactive species and diabetes: counteracting oxidative stress to improve health,” Current Opinion in Pharmacology, vol. 9, no. 6, pp. 771–779, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. Q. Ma, “Transcriptional responses to oxidative stress: pathological and toxicological implications,” Pharmacology and Therapeutics, vol. 125, no. 3, pp. 376–393, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Riechelmann, “Cellular and molecular mechanisms in environmental and occupational inhalation toxicology,” GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery, vol. 3, 2004. View at Google Scholar
  15. S. Tafazoli, D. D. Spehar, and P. J. O'Brien, “Oxidative stress mediated idiosyncratic drug toxicity,” Drug Metabolism Reviews, vol. 37, no. 2, pp. 311–325, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. P. J. O'Brien and A. G. Siraki, “Accelerated cytotoxicity mechanism screening using drug metabolising enzyme modulators,” Current Drug Metabolism, vol. 6, no. 2, pp. 101–109, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. A. Maruf, L. Wan, and P. J. O'Brien, “Evaluation of azathioprine-induced cytotoxicity in an in vitro rat hepatocyte system,” BioMed Research International, vol. 2014, Article ID 379748, 7 pages, 2014. View at Publisher · View at Google Scholar
  18. S. L. MacAllister, C. Young, A. Guzdek, N. Zhidkov, and P. J. O'Brien, “Molecular cytotoxic mechanisms of chlorpromazine in isolated rat hepatocytes,” Canadian Journal of Physiology and Pharmacology, vol. 91, no. 1, pp. 56–63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Tafazoli and P. J. O'Brien, “Accelerated cytotoxic mechanism screening of hydralazine using an in vitro hepatocyte inflammatory cell peroxidase model,” Chemical Research in Toxicology, vol. 21, no. 4, pp. 904–910, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Tafazoli and P. J. O'Brien, “Amodiaquine-induced oxidative stress in a hepatocyte inflammation model,” Toxicology, vol. 256, no. 1-2, pp. 101–109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Chan, H.-J. Lehmler, M. Sivagnanam, C. Y. Feng, L. Robertson, and P. J. O'Brien, “Cytotoxic effects of polychlorinated biphenyl hydroquinone metabolites in rat hepatocytes,” Journal of Applied Toxicology, vol. 30, no. 2, pp. 163–171, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Olfert, B. Cross, and A. McWilliam, Guide to the Care and Use of Experimental Animals, Canadian Council on Animal Care, Ottawa, Canada, 1st edition, 1993.
  23. P. Moldéus, J. Högberg, and S. Orrenius, “Isolation and use of liver cells,” Methods in Enzymology, vol. 52, pp. 60–71, 1978. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Lee, Y. Miki, H. Katsura, and K. Kariya, “Mechanism of inactivation of myeloperoxidase by propylthiouracil,” Biochemical Pharmacology, vol. 39, no. 9, pp. 1467–1471, 1990. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Possel, H. Noack, W. Augustin, G. Keilhoff, and G. Wolf, “2,7-Dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite formation,” FEBS Letters, vol. 416, no. 2, pp. 175–178, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. M. T. Smith, H. Thor, P. Hartzell, and S. Orrenius, “The measurement of lipid peroxidation in isolated hepatocytes,” Biochemical Pharmacology, vol. 31, no. 1, pp. 19–26, 1982. View at Publisher · View at Google Scholar · View at Scopus
  27. A. L. Bulteau, S. Planamente, L. Jornea et al., “Changes in mitochondrial glutathione levels and protein thiol oxidation in ∆yfh1 yeast cells and the lymphoblasts of patients with Friedreich's ataxia,” Biochimica et Biophysica Acta: Molecular Basis of Disease, vol. 1822, no. 2, pp. 212–225, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. B. S. Andersson, T. Y. Aw, and D. P. Jones, “Mitochondrial transmembrane potential and pH gradient during anoxia,” American Journal of Physiology—Cell Physiology, vol. 252, no. 4, pp. 349–355, 1987. View at Google Scholar · View at Scopus
  29. K. E. Brown, E. M. Brunt, and J. W. Heinecke, “Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver,” The American Journal of Pathology, vol. 159, no. 6, pp. 2081–2088, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Kato, H. Yoshidome, M. J. Edwards, and A. B. Lentsch, “Regulation of liver inflammatory injury by signal transducer and activator of transcription-6,” American Journal of Pathology, vol. 157, no. 1, pp. 297–302, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Tafazoli and P. J. O'Brien, “Peroxidases: a role in the metabolism and side effects of drugs,” Drug Discovery Today, vol. 10, no. 9, pp. 617–625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. A. M. L. Zatón and E. Ochoa de Aspuru, “Horseradish peroxidase inhibition by thiouracils,” FEBS Letters, vol. 374, no. 2, pp. 192–194, 1995. View at Publisher · View at Google Scholar · View at Scopus
  33. S. J. Klebanoff and A. M. Waltersdorph, “Inhibition of peroxidase-catalyzed reactions by deferoxamine,” Archives of Biochemistry and Biophysics, vol. 264, no. 2, pp. 600–606, 1988. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Chan, N. S. Jensen, P. M. Silber, and P. J. O'Brien, “Structure-activity relationships for halobenzene induced cytotoxicity in rat and human hepatoctyes,” Chemico-Biological Interactions, vol. 165, no. 3, pp. 165–174, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. P. J. O'Brien, K. Chan, and P. M. Silber, “Human and animal hepatocytes in vitro with extrapolation in vivo,” Chemico-Biological Interactions, vol. 150, no. 1, pp. 97–114, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. A. S. Rosman, C. Frissora-Rodeo, A. T. Marshall, B. P. Reiter, and F. Paronetto, “Cholestatic hepatitis following flutamide,” Digestive Diseases and Sciences, vol. 38, no. 9, pp. 1756–1759, 1993. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Pessayre and D. Larrey, “Drug-induced liver injury,” in Oxford Textbook of Clinical Hepatology, N. McIntyre, J. Benhamou, J. Bircher, M. Rizzeto, and J. Rodes, Eds., pp. 875–902, Oxford University Press, Oxford, UK, 2nd edition, 1991. View at Google Scholar
  38. L. J. Núnez-Vergara, D. Farias, S. Bollo, and J. A. Squella, “An electrochemical evidence of free radicals formation from flutamide and its reactivity with endo/xenobiotics of pharmacological relevance,” Bioelectrochemistry, vol. 53, no. 1, pp. 103–110, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Kashimshetty, V. G. Desai, V. M. Kale et al., “Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity,” Toxicology and Applied Pharmacology, vol. 238, no. 2, pp. 150–159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Zafarullah, W. Q. Li, J. Sylvester, and M. Ahmad, “Molecular mechanisms of N-acetylcysteine actions,” Cellular and Molecular Life Sciences, vol. 60, no. 1, pp. 6–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Kang, D. Dalvie, E. Smith, S. Zhou, and A. Deese, “Identification of a novel glutathione conjugate of flutamide in incubations with human liver microsomes,” Drug Metabolism and Disposition, vol. 35, no. 7, pp. 1081–1088, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Hamad, N. Arda, M. Pekmez, S. Karaer, and G. Temizkan, “Intracellular scavenging activity of Trolox (6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid) in the fission yeast, Schizosaccharomyces pombe,” Journal of Natural Science, Biology and Medicine, vol. 1, no. 1, pp. 16–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. S. S. Leonard, C. Xia, B.-H. Jiang et al., “Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses,” Biochemical and Biophysical Research Communications, vol. 309, no. 4, pp. 1017–1026, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Zini, C. Morin, A. Bertelli, A. A. E. Bertelli, and J.-P. Tillement, “Effects of resveratrol on the rat brain respiratory chain,” Drugs under Experimental and Clinical Research, vol. 25, no. 2-3, pp. 87–97, 1999. View at Google Scholar · View at Scopus
  45. N. R. Di Luzio and F. Costales, “Inhibition of the ethanol and carbon tetrachloride induced fatty liver by antioxidants,” Experimental and Molecular Pathology, vol. 4, no. 2, pp. 141–154, 1965. View at Publisher · View at Google Scholar · View at Scopus
  46. V. E. Kagan, J. Jiang, H. Bayir, and D. A. Stoyanovsky, “Targeting nitroxides to mitochondria: location, location, location, and ...concentration. Highlight Commentary on ‘Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide’,” Free Radical Biology and Medicine, vol. 43, no. 3, pp. 348–350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. S. M. Vaz and O. Augusto, “Inhibition of myeloperoxidase-mediated protein nitration by tempol: kinetics, mechanism, and implications,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 24, pp. 8191–8196, 2008. View at Publisher · View at Google Scholar · View at Scopus